{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:16:21Z","timestamp":1775304981433,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tcmonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.tcm.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T17:09:38Z","timestamp":1409591378000},"page":"360-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Aspirin in the primary prevention of cardiovascular disease: Current knowledge and future research needs"],"prefix":"10.1016","volume":"24","author":[{"given":"Charles H.","family":"Hennekens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2014.08.006_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjmed.2012.12.013","article-title":"Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions","volume":"126","author":"Hennekens","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jama.2011.322","article-title":"Statistical association and causation: contributions of different types of evidence","volume":"306","author":"Hennekens","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2014.08.006_bib3","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/jama.2009.1756","article-title":"The need for large scale randomized evidence without undue emphasis on small trials, meta-analyses or subgroup analyses","volume":"302","author":"Hennekens","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2014.08.006_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib5","first-page":"349","article-title":"Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archinte.1994.00420010055007","article-title":"The benefits of aspirin in acute myocardial infarction: still a well-kept secret in the U.S.","volume":"154","author":"Hennekens","year":"1994","journal-title":"Arch Int Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib8","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"The chinese acute stroke trial","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJM198801283180431","article-title":"Preliminary report on the aspirin component of the ongoing Physicians\u05f3 Health Study","volume":"318","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u05f3 Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomized trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.tcm.2014.08.006_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM198804073181412","article-title":"An overview of the British and American aspirin studies","volume":"318","author":"Hennekens","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib13","first-page":"49652","volume":"64","year":"1999","journal-title":"Fed Regist"},{"key":"10.1016\/j.tcm.2014.08.006_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJMe058051","article-title":"The puzzle of aspirin and sex","volume":"352","author":"Levin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ncpcardio0420","article-title":"Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis","volume":"3","author":"Hennekens","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib19","doi-asserted-by":"crossref","unstructured":"Huxley TH. Discourses Biological and Geological. Part Eight. New York: Kessinger Publishing; 1894. [Collected Essays of Thomas Huxley].","DOI":"10.5962\/bhl.title.25446"},{"key":"10.1016\/j.tcm.2014.08.006_bib20","doi-asserted-by":"crossref","DOI":"10.2217\/fca.14.49","article-title":"Evolving concepts in cardiovascular disease treatment and prevention: aspirin then and now","author":"Hennekens","year":"2014","journal-title":"Future Cardiol"},{"key":"10.1016\/j.tcm.2014.08.006_bib21","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomized controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.08.006_bib22","doi-asserted-by":"crossref","DOI":"10.4155\/cli.13.31","article-title":"The risks and benefits of prophylactic aspirin in vascular disease and cancer: what\u05f3s a doctor to do?","author":"Hennekens","year":"2013","journal-title":"Clin Invest"},{"key":"10.1016\/j.tcm.2014.08.006_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1074248406292263","article-title":"Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions","volume":"11","author":"Hennekens","year":"2006","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.tcm.2014.08.006_bib24","first-page":"316","article-title":"Aspirin trial: interim results","volume":"296","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.tcm.2014.08.006_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complication: systematic review of epidemiologic studies","volume":"52","author":"Garcia Rodriguez","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.tcm.2014.08.006_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/JMDH.S54324","article-title":"Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment","volume":"7","author":"Cryer","year":"2014","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.tcm.2014.08.006_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.tcm.2014.08.006_bib28","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","article-title":"Efficacy of esomeprazole (20mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin","volume":"103","author":"Yeomans","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"136","key":"10.1016\/j.tcm.2014.08.006_bib29","first-page":"157","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2014.08.006_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disese and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2014.08.006_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrcardio.2012.26","article-title":"Aspirin in primary prevention-good news and bad news","volume":"9","author":"Hennekens","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2014.08.006_bib32","unstructured":"Bayer HealthCare. ARRIVE: Aspirin to reduce risk of initial vascular events. Online; http:\/\/www.arrive-study.com\/EN\/. July 14, 2014."},{"key":"10.1016\/j.tcm.2014.08.006_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2165\/00002512-200320120-00004","article-title":"Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: aspirin in reducing events in the elderly (ASPREE)","volume":"20","author":"Nelson","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.tcm.2014.08.006_bib34","unstructured":"University of Oxford. ASCEND: a study of cardiovascular events in diabetes. Online; http:\/\/www.ctsu.ox.ac.uk\/ascend\/. July 14, 2014."},{"key":"10.1016\/j.tcm.2014.08.006_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-8-21","volume":"8","author":"De Berardis","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.tcm.2014.08.006_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2014.88","article-title":"Aspirin in the primary prevention of cardiovascular disease: the need for individual clinical judgments based on absolute benefits and risks","author":"Hennekens","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2014.08.006_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/107424840200700203","article-title":"Use of statins and aspirin to reduce risks of cardiovascular disease","volume":"7","author":"Herbert","year":"2002","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.tcm.2014.08.006_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archinte.164.1.40","article-title":"Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses","volume":"164","author":"Hennekens","year":"2004","journal-title":"Arch Intern Med"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173814001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173814001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T04:44:09Z","timestamp":1717303449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173814001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1050173814001108"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2014.08.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin in the primary prevention of cardiovascular disease: Current knowledge and future research needs","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}